The biopharmaceutical firm Viking Therapeutics approaches a critical juncture as it prepares to unveil new clinical findings for its obesity treatment candidate, VK2735. These highly anticipated ...

Research sheds light on health outcomes and insurance coverage for patients treated with GLP-1s, and how technology is ...